Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alltrna
Biotech
Amylyx preps for GLP-1 launch with new CCO—Chutes & Ladders
Amylyx preps for GLP-1 launch with new CCO. Andy Orth given key to the City. Antag taps Bayer vet as CEO.
Darren Incorvaia
,
Zoey Becker
Jan 10, 2025 8:30am
3 Flagship biotechs make key exec hires—Chutes & Ladders
Aug 18, 2023 9:30am
Flagship's Alltrna collects $109M to Stop Codon Disease
Aug 9, 2023 6:00am
Ayala, Advaxis merger means new leadership team—Chutes & Ladders
Oct 21, 2022 9:30am
Takeda, Arch fund hC Bio with $24M for transfer RNAs
Feb 24, 2022 11:00am
After Moderna success, Flagship's next RNA bet: $50M for Alltrna
Nov 9, 2021 6:30am